Managing Vulvovaginal Candidiasis—Riding the Wave of Therapeutic Change - a podcast by ReachMD

CME credits: 0.50

Valid until: 02-11-2022

Claim your CME credit at https://reachmd.com/programs/cme/managing-vulvovaginal-candidiasisriding-wave-therapeutic-change/13040/

The global burden of acute vulvovaginal candidiasis (VVC) and the substantial morbidity and poor quality of life associated with recurrent disease (RVVC) requires improved solutions and quality of care for affected women. Join Dr. Paul Nyirjesy as he dissects the barriers to managing VVC and RVVC in your clinical practice and provides both diagnostic and therapeutic guidance inclusive of newly emerging and novel agents. These agents have unique qualities that may well represent a significant step forward in how you manage this challenging infection.

Further episodes of ReachMD CME

Further podcasts by ReachMD

Website of ReachMD